Investing in Innovation Africa (i3), a pan-African initiative for startups building the future of healthcare supply chains, is calling for leading innovators to join its second cohort.
Funded by the Bill & Melinda Gates Foundation and sponsored by AmerisourceBergen, Merck Sharpe & Dohme (MSD), Microsoft and Chemonics, i3 is supporting the commercialisation of 60 promising early and growth stage companies.
The programme connects African-led supply chain innovators to donors, industry, and government partners, to power startups’ growth and impact. Selected startups receive targeted introductions to customers to support commercialisation and impact, a US$50,000 grant, and tailored investment readiness support. i3 is particularly focused on selecting women-led companies and those operating in Francophone regions.
Applications are open here until June 26. Selected startups will be announced on September 14. The first cohort, selected in September 2022, featured 31 innovators enhancing access to health products across more than 24,000 hospitals, clinics, and pharmacies in 26 African countries.
